PTAB’s Denial of IPR Petition Forecloses Defendant’s Inequitable Conduct Claim in District Court

May 15, 2020

Reading Time : 2 min

The defendant filed the IPR petition during the course of the infringement litigation. The defendant’s petition relied on the same prior art references that underpinned its proposed inequitable conduct claim. However, while the defendant’s motion to amend to add that claim was pending in the district court, the PTAB denied institution of the IPR. In doing so, the PTAB “expressly considered the . . . prior art references (which are the subject of [the defendant]’s inequitable conduct claim[]) and found that [the defendant] could not demonstrate a reasonable likelihood that such references would have rendered any claim of the [asserted] patent unpatentable.” Order at 6.

The district court subsequently denied the defendant’s motion to amend. The court first explained that leave to amend under Rule 15(a) “should be denied . . . [when] the amendment would be futile,” and that an “amendment is futile where [it] fails to state a claim as required by Rule 12(b)(6).” Id. at 2. The court then explained that, despite its general obligation under Rule 12(b)(6) to “accept all factual allegations in [a] pleading as true, [it] need not accept factual allegations ‘that contradict matters properly subject to judicial notice,’” such as the PTAB’s decision. Id. at 6 (quoting Veney v. Wyche, 293 F.3d 726, 730 (4th Cir. 2002)).

The court next examined the impact of the PTAB’s decision on the defendant’s proposed inequitable conduct claim. The court observed that “[t]o plead an inequitable conduct claim, [the defendant] must sufficiently plead materiality—that ‘but for’ the [undisclosed] prior art, the [Patent and Trademark Office] would not have allowed a claim in the [asserted] patent.” Id. In turn, the court stressed that, regardless of the defendant’s allegations of materiality in the proposed amendment, “the Court knows that the PTAB considered the [defendant’s relied-upon] prior art and did not find it material to patentability.” Id. (emphasis in original).

The court thus concluded that, “[i]n light of the PTAB’s decision denying IPR,” and even “assuming all [of the defendant’s] other factual allegations as true,” the proposed amendment did “not plausibly give rise to an entitlement to relief because [the defendant] cannot show that ‘but for’ the [relied-upon] prior art, the PTO would not have issued [] the [asserted] patent.” Id. at 7. In reaching its holding, the court rejected the defendant’s argument that it “should completely refrain from examining the merits of [the] inequitable conduct counterclaim and affirmative defense and only examine whether [the defendant] has sufficiently pleaded inequitable conduct.” Id. at 8. As the court observed, “this argument ignores the [] requirement to consider whether any amendment is futile . . . , and accordingly whether any amendment would withstand a motion to dismiss.” Id.

Practice Tip: The Jaguar decision exemplifies that a PTAB’s refusal to institute an IPR, even if not binding on a district court, can still have significant ramifications in infringement litigation involving the same patent. Although filing an IPR petition is a common tactic for alleged infringers, they should recognize that a negative ruling from the PTAB might effectively foreclose an inequitable conduct claim in district court. Similarly, a plaintiff facing an inequitable conduct claim based on failure to disclose prior art should consider whether the PTAB previously assessed the patentability of the asserted claims in light of that prior art.

Jaguar Land Rover Ltd. v. Bentley Motors Limited, No. 2:18-cv-320 (E.D. Va. Apr. 30, 2020)

Share This Insight

Previous Entries

IP Newsflash

June 5, 2026

The Supreme Court unanimously held that for a complaint of induced infringement, a patent owner must allege that the accused infringer took affirmative, not passive, steps to encourage direct infringement. Thus, where a generic drug has a skinny label, to induce infringement of the carved-out patented use of the drug, the generic company must have taken steps that were designed to cause others to perform the patented use, not just steps that could cause such conduct.

...

Read More

IP Newsflash

May 07, 2026

The Northern District of Illinois granted a summary judgment motion of no invalidity based on indefiniteness because the qualitative terms like “sufficiently slow” and “desired period of time” were definite when viewed in light of the surrounding claim language and specification.

...

Read More

IP Newsflash

April 9, 2026

In the April 1, 2026 edition of the Official Gazette, the U.S. Patent and Trademark Office announced a new procedural framework that permits patent owners to submit a limited, early response to a request for ex parte reexamination.

...

Read More

IP Newsflash

March 12, 2026

The Northern District of Illinois recently dismissed a complaint without prejudice for failing to plausibly allege patent infringement. The court found that the allegations of direct infringement were insufficiently pled where the images of the accused product included in the complaint did not appear to show a particular necessary element of the claims.

...

Read More

© 2026 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.